Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial

  Yves Lévy ^{1, 2} AuthorId : 316376
Author

  Christine Lacabaratz ¹ AuthorId : 176364
Author

  Kim Ellefsen-Lavoie ³ AuthorId : 12213570
Author

  Wolfgang Stöhr ⁴ AuthorId : 11215193
Author

  Jean-Daniel Lelièvre ¹ AuthorId : 316373
Author

  Pierre-Alexandre Bart ² AuthorId : 12213571
Author

  Odile Launay ⁵ AuthorId : 638188
Author

  Jonathan Weber ⁶ AuthorId : 685069
Author IdHAL : jonathan-weber

  Bernd Salzberger ³ AuthorId : 11480576
Author

  Aurélie Wiedemann ¹ AuthorId : 468921
Author

  Mathieu Surénaud ¹ AuthorId : 537569
Author

  David Koelle ⁷ AuthorId : 12111410
Author

  Hans Wolf ⁸ AuthorId : 12213572
Author

  Ralf Wagner ⁸ AuthorId : 1106274
Author

  Véronique Rieux ¹ AuthorId : 12213573
Author

  David Montefiori ⁹ AuthorId : 12213574
Author

  Nicole Yates ⁹ AuthorId : 11790544
Author

  Georgia Tomaras ⁹ AuthorId : 1425270
Author

  Raphael Gottardo ¹⁰ AuthorId : 351911
Author

  Bryan Mayer ¹⁰ AuthorId : 12213575
Author

  Song Ding ¹¹ AuthorId : 12213576
Author

  Rodolphe Thiébaut ¹² AuthorId : 1414099
Author IdHAL : rodolphe-thiebaut ORCID : https://orcid.org/0000-0002-5235-3962

  Sheena Mccormack ⁴ AuthorId : 570636
Author

  Geneviève Chêne ¹³ AuthorId : 84027
Author

  Giuseppe Pantaleo ³ AuthorId : 1406624
Author